AP
ABBV icon

Aspect Partners’s AbbVie ABBV Stock Holding History

Aspect Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.7K Hold
249
– – 0.02% 137
2026
Q1 		$54.2K Hold
249
– – 0.02% 133
2025
Q4 		$56.9K Hold
249
– – 0.02% 139
2025
Q3 		$57.7K Sell
249
-212
-46% -$43.2K 0.03% 146
2025
Q2 		$85.6K Buy
461
+212
+85% +$39.4K 0.04% 122
2025
Q1 		$52.2K Sell
249
-6
-2% -$1.17K 0.03% 127
2024
Q4 		$45.3K Sell
255
-32
-11% -$5.88K 0.03% 135
2024
Q3 		$56.7K Hold
287
– – 0.03% 115
2024
Q2 		$49.2K Hold
287
– – 0.03% 120
2024
Q1 		$52.3K Hold
287
– – 0.04% 117
2023
Q4 		$44.5K Buy
+287
New +$41.8K 0.03% 122

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aspect Partners's ABBV Position: Q2 2026 in Review

Aspect Partners held its AbbVie (ABBV) position steady in Q2 2026 at 249 shares worth $62.7K. The position accounts for 0.02% of the portfolio, ranked #137.

Aspect Partners first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $85.6K in Q2 2025. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Aspect Partners held 249 shares of AbbVie worth $62.7K as of Q2 2026.
  • Aspect Partners left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.02% of Aspect Partners's portfolio in Q2 2026, its #137 holding.
  • Aspect Partners first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • Aspect Partners's AbbVie position peaked at $85.6K in Q2 2025.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.